Skip to main content
. 2020 Mar 16;12(3):701. doi: 10.3390/cancers12030701

Figure 1.

Figure 1

Mutation map (A) showing frequency of gene mutations detected by Guardant360 across all and individual cancer subtypes and their associated categories of cell survival, cell fate, and genome maintenance. (B) Matched TP53 alterations detected by both Guardant360 and Caris in cancer subtypes.